Nathaniel Calloway's Insider Trades & SAST Disclosures

Nathaniel Calloway's most recent trade in Anebulo Pharmaceuticals Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 4, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Anebulo Pharmaceuticals Inc
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2025 25,000 25,000 - - Stock Option (right to buy)
Anebulo Pharmaceuticals Inc
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2025 3,309 3,309 - - Stock Option (right to buy)
Lifecore Biomedical Inc
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 30,000 58,069 (0%) 0% - Common Stock
Anebulo Pharmaceuticals Inc
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Anebulo Pharmaceuticals Inc
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 1,655 1,655 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades